News & Events

2021 psilocybin study
November 29, 2021

Extensive Psilocybin Trial Shows Great Promise for Treating Serious Depression

Although Small Number Serious Adverse Events Were Reported SafeMinds Shares has reported previously on psilocybin, a hallucinogenic/psychedelic substance that works by activating serotonin receptors in the prefrontal cortex, the area of the brain that affects mood, cognition, and perception. Early trials have shown that the psychedelic holds promise as an autism treatment since it supports […]

November 22, 2021

Study Claims Microbiome Not a Causal Factor in Autism Spectrum Disorder

Research Suggests that Picky Eating Causes Differences in Gut Bacteria A bold new Australian study asserts that gut health “is no way a cause of why the brain develops differently” in individuals with autism. The researchers involved in this effort claim that previous studies linking microbiome contents to autism have been underpowered and not designed […]

safeminds community shares
November 22, 2021

Community Shares | November 22, 2021

The U.S. House of Representatives passed the Build Back Better Act last Friday. The bill includes $150 billion for in home and community-based services. If the legislation is passed by the Senate and signed into law by the president, it will support individuals with autism throughout the country. Research from Sweden demonstrates that exercise is […]

November 22, 2021

Appropriate ‘Forever Homes’ for Adults with Autism Are Possible, Yet Uncommon

One Adult Celebrates 10 Incredible Years at His Residential Placement  Nate Goehner is an adult living with autism. He arrived at The Center for Discovery, located in New York’s Hudson Valley, when he was just 17 years old. Now 27, Nate has lived and thrived on the center’s 1500 acres for a decade. The Center […]

November 22, 2021

Brain Stimulation Protocol Results in Remission of Depression for 79% of Patients

Non-Invasive Treatment Produced No Adverse Events During Clinical Trial Research has shown that individuals with autism are 4-times more likely to experience depression over their lifetime compared to people without the disorder. Due to this fact, a recently released placebo-controlled test out of Stanford University’s Medical Center should be very interesting to the autism community. […]

November 15, 2021

Community Shares | November 15, 2021

Two new rodent studies have associated maternal autoantibodies with the development of autism, according to an article in Spectrum. Antibodies can pass from a pregnant woman’s placenta to her developing fetus. Most antibodies are protective and beneficial. However, the report details how certain forms of antibodies–called “auto-antibodies”–can attack a fetus’ brain cells and affect its development.  […]

Show Buttons
Hide Buttons